Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/21/18 Allergy Therapeutics (AGY:LN) Pollinex Quattro Grass for Allergic Rhinitis Subscribers Only Subscribers Only Subscribers Only
5/21/18 Nabriva Therapeutics (NBRV) Lefamulin for Community Acquired Pneumonia (CAP) (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
5/21/18 Immunomedics (IMMU) Sacituzumab Govitecan for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
5/21/18 Fortress (FBIO) IV Tramadol for Postsurgical Pain Subscribers Only Subscribers Only Subscribers Only
5/21/18 Harmony Wakix for Narcolepsy Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/22/18 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
05/22/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/22/18 Subscribers Only Subscribers Only Trial Data - Updated Results
05/22/18 Subscribers Only Subscribers Only Trial Data - Other
05/22/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top